M2-Mφs suppress tumor immunity and accelerate tumor progression by secreting immune suppressive factors, such as cytokines (TGF-β and IL-10) and chemokines (CCL2, CCL17, CCL22, and CCL24) (33, 34). Here, CCL22 is linked to neoplasm.